Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
4
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
4
×
biotech
clinical trials
deals
amgen
fda
hepatitis b
inclisiran
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
alexion pharmaceuticals
alirocumab
beijing
boehringer ingelheim
boston
brii bio
brii biosciences
china
cholesterol
dicerna pharamceuticals
evolocumab
glaxosmithkline
gsk
hepatitis b virus
hereditary transthyretin amyloidosis
novartis
patisiran
pcsk9
praluent
raleigh-durham
raleigh-durham blog main
What
drug
4
×
medicines
4
×
cholesterol
disease
fda
hepatitis
medco
new
acquire
adds
agreed
alliance
areas
billion
biosciences
bio’s
brii
bringing
brings
cash
caught
causing
clears
closer
company
compound
deal
dicerna
earlier
eye
filing
gene
inched
infectious
intended
launched
lowering
market
million
mission
Language
unset
Current search:
medicines
×
drug
×
" alnylam pharmaceuticals "
×
" national top stories "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline